TickerFacts.

Abvc Biopharma, Inc. (ABVC): Cost of Revenue

Annual figures by period end, from SEC filings.

$763
Year ended 2024-12-31
-46.9%
3-year compound annual growth
-48.0%
5-year compound annual growth
$302.0K2014-09-18: $02015-09-30: $5212016-09-30: $322018-12-31: $185.3K2019-12-31: $20.1K2020-12-31: $18.7K2021-12-31: $5.1K2022-12-31: $286.4K2023-12-31: $302.0K2024-12-31: $763$763
2014-09-18 Cost of Revenue (USD) 2024-12-31
Period endedCost of RevenueChange YoYSource filing
2024-12-31$763-99.7%2026-03-03, From 2024-01-01
2023-12-31$302.0K+5.5%2025-04-15, From 2023-01-01
2022-12-31$286.4Kn/m2024-03-13, From 2022-01-01
2021-12-31$5.1K-72.8%2023-03-31, From 2021-01-01
2020-12-31$18.7K-7.1%2022-03-31, From 2020-01-01
2019-12-31$20.1K-89.1%2021-03-16, From 2019-01-01
2018-12-31$185.3Kn/a2020-05-15, From 2018-01-01
No annual figure between 2016-09-30 and 2018-12-31.
2016-09-30$32-93.9%2018-01-16, From 2015-10-01
2015-09-30$521n/a2015-11-27, From 2014-10-01
2014-09-18$0n/a2015-11-27, From 2013-10-01